Publications:82
- Mount Sinai Doctors
James F Sumowski, PhD
Psychology
About Me
James F. Sumowski, Ph.D. is an Associate Professor of Neurology at Mount Sinai and the clinical neuropsychologist at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis (MS). Dr. Sumowski is an expert on cognition in persons with MS, and he introduced the concept of “reserve” against cognitive decline in MS: the observation that genetic and environmental factors can moderate deleterious effects of disease on functional outcomes (representative article: Sumowski et al., Neurology 2014). The Sumowski Laboratory works to advance understanding and improvement of functional outcomes. Toward this end, Dr. Sumowski is the PI of a large prospective National Institutes of Health (NIH / NICHD) R01 grant to identify modifiable risk and protective factors linked to cognitive decline, which will inform future interventions.
Dr. Sumowski is a leader in the field. He recently led an international group of MS experts toward a joint statement of knowledge gaps, obstacles, and research priorities for the field of cognition in persons with MS (Sumowski et al., Neurology 2018). In addition to outlining several specific recommendations for research and clinical practice, the statement highlights the critical need to develop testable and biologically plausible models of cognitive decline due to MS, which will lay the groundwork for much-needed evidence-based rehabilitation.
Language
English
Position
PROFESSOR | Neurology
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Cognitive Neuroscience, Depression, Memory, Multiple Sclerosis
Clinical Focus
- Memory Disorder
- Multiple Sclerosis
- Neuromyelitis Optica
- Neuropsychological testing
Education
BA, Seton Hall University
PhD, Columbia University
Internship, Clinical Neuropsychology
Long Island Jewish Medical Center
Fellowship, Clinical Neuropsychology
Rutgers New Jersey Medical School
Research
Memory deficits are among the most common cognitive difficulties experienced by persons with multiple sclerosis (MS), with negative consequences for employment and overall quality of life. There are currently no validated treatments for MS memory impairment. Dr. Sumowski has published early stage research investigating memory interventions through the use of cognitive strategies, lifestyle modifications, and pharmaceutical interventions. Dr. Sumowski is engaging in research to better understand the neural basis of memory deficits due to MS, which will inform the development of novel treatments with greater promise for success.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Myelopoiesis is temporally dynamic and is regulated by lifestyle to modify multiple sclerosis. Abi G. Yates, Annie Khamhoung, Lena Gaebel, Walter Jacob, Daniel E. Radford-Smith, Máté G. Kiss, Pacific Huynh, Teresa Gerhardt, Merlin Heiser, Oren Cohen, Filip K. Swirski, Daniel C. Anthony, James Sumowski, Ilana Katz Sand, Cameron S. McAlpine. Nature Communications
- Multiple Sclerosis Cognitive Scale (MSCS): A brief psychometrically robust metric of patient-reported cognitive difficulty. James F. Sumowski, Joshua Sandry. Multiple Sclerosis Journal
- Correlations Between Oculometric Measures and Traditional Clinical Assessments in Multiple Sclerosis. S. Levy, I. B. Katz Sand, O. Berkman, E. Raveh, E. Ben-Ami, R. Kreitman, J. F. Sumowski. Multiple Sclerosis and Related Disorders
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sumowski has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.